Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374609 | Bioorganic & Medicinal Chemistry Letters | 2010 | 5 Pages |
A structure–activity relationship study of the lead piperazinylcarbonylpiperidine compound 3 resulted in the identification of 4-benzimidazolyl-piperidinylcarbonyl-piperidine 6h as a histamine-3 (H3) receptor antagonist. Additional optimization of 6h led to the identification of compounds 11i–k with Ki ⩽ 0.5 nM and good in vivo activity.
Graphical abstractA structure–activity relationship study of the lead piperazinylcarbonylpiperidine compound 3 has resulted in the identification of 4-benzimidazolyl-piperidinylcarbonyl-piperidine 6h as a histamine-3 (H3) receptor antagonist. Additional optimization of 6h led to the identification of compounds 11i–k with Ki < 0.5 nM and good in vivo activity.Figure optionsDownload full-size imageDownload as PowerPoint slide